Clever Leaves Holdings Inc (CLVR)
1.08
-0.02 (-1.82%)
USD |
NASDAQ |
Jun 24, 16:00
1.06
-0.02 (-1.85%)
After-Hours: 20:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 43.35M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -89.65% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 1.635 |
| Price to Book Value | 0.5160 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.2744 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | -- |
News
Headline
Wire
Time (ET)
SA Breaking News
06/08 11:49
PR Newswire
06/08 08:45
Yahoo
05/17 07:53
MT Newswires
05/13 13:05
MT Newswires
05/12 16:24
Globe Newswire
04/28 08:30
MT Newswires
04/27 11:05
SA Breaking News
04/27 10:01
Events
| DATE | TIME | TYPE | PERIOD | REPORTED EPS |
ESTIMATED EPS |
SURPRISE | |
| 08/12/2022* | -- | Results | Q2 2022 | -- | -0.23 | -- | |
| 08/12/2022* | 17:00 EST | Earnings Call | Q2 2022 | -- | -- | -- | |
| 05/12/2022 | -- | Results | Q1 2022 | -0.50 | -0.52 | 4.62% | |
| 05/12/2022 | 17:00 EST | Earnings Call | Q1 2022 | -- | -- | -- | |
| 03/24/2022 | -- | Results | Q4 2021 | -0.21 | -0.62 | 65.82% | |
| 03/24/2022 | 17:00 EST | Earnings Call | Q4 2021 | -- | -- | -- | |
| 11/10/2021 | -- | Results | Q3 2021 | -0.09 | -0.40 | 76.90% | |
| 11/10/2021 | 17:00 EST | Earnings Call | Q3 2021 | -- | -- | -- |
*Estimated Date/Time
Earnings
Profile
Edit
| Clever Leaves Holdings Inc is a producer of pharmaceutical and consumer cannabis brands. The company operates and has investments in Canada, Colombia, Germany, Portugal, and the United States. |
| URL | https://www.cleverleaves.com |
| Investor Relations URL | N/A |
| HQ State/Province | Florida |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Equity Style | Small Cap/Value |
| Next Earnings Release | Aug. 12, 2022 (est.) |
| Last Earnings Release | May. 12, 2022 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Analyst Coverage
|
Consensus Rating
|
|
|
Analyst Recommendation
|
|
Source: S&P Global
Dividends
| Dividend Per Share (TTM) | -- |
|
2017
2018
2019
2020
2021
6.00%
4.00%
2.00%
|
|
| Yield to Market | 0.00 |
| Yield to Sector | 0.00 |
| Yield to Industry | 0.00 |
| Last Dividend Amt. | -- |
| Dividend Frequency | -- |
| Last Ex-Dividend Date | -- |
| Yield (TTM) | 0.00% |
| Forward Yield | -- |
| Payout Ratio | 0.00% |
| Cash Payout Ratio | 0.00% |
| Consistent Payer (5Y) | No |
| Consistent Growth (5Y) | No |
Risk Info
Total Returns Comparison
Annual Total Returns Versus Peers
As of June 24, 2022.
Fundamentals
| Revenue (TTM) | 17.12M |
| Total Expenses (TTM) | 55.94M |
| Net Income (TTM) | -48.10M |
| Total Assets (Quarterly) | 127.22M |
| Total Liabilities (Quarterly) | 44.77M |
| Shareholders Equity (Quarterly) | 82.45M |
| Cash from Operations (TTM) | -35.98M |
| Cash from Investing (TTM) | -6.279M |
| Cash from Financing (TTM) | 17.89M |
Ratings
Profile
Edit
| Clever Leaves Holdings Inc is a producer of pharmaceutical and consumer cannabis brands. The company operates and has investments in Canada, Colombia, Germany, Portugal, and the United States. |
| URL | https://www.cleverleaves.com |
| Investor Relations URL | N/A |
| HQ State/Province | Florida |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Equity Style | Small Cap/Value |
| Next Earnings Release | Aug. 12, 2022 (est.) |
| Last Earnings Release | May. 12, 2022 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Risk Info
Ownership
| Insider Ownership Percentage | Upgrade |
Jul '20
Nov '20
Mar '21
80.00%
40.00%
10.00%
Analyst Coverage
|
Consensus Rating
|
|
|
Analyst Recommendation
|
|
Source: S&P Global
Other Resources
| Whale Wisdom | 13F Filings |
| Seeking Alpha | Call Transcripts |
| Morningstar | Insider Trading |
| Nasdaq | Institutional Ownership |
| Nasdaq | Option Chain |
| SEC | SEC Filings |
| CLVR Tweets |